Magnesium: study protocols
15 study groups say how much Magnesium participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
23,675 products in our catalogue print how much Magnesium a serving holds.
Most common: 50 mg to 100 mg, 22% of 23,675 products.
| Dose per serving | Products |
|---|---|
| 5 mg or less | 1,041 |
| 5 mg to 10 mg | 1,179 |
| 10 mg to 25 mg | 3,511 |
| 25 mg to 50 mg | 4,968 |
| 50 mg to 100 mg | 5,288 |
| 100 mg to 250 mg | 5,056 |
| 250 mg to 500 mg | 2,340 |
| over 500 mg | 292 |
Dose per serving from research
11 study groups in 8 studies say how much Magnesium participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g, 36% of 11 study groups.
| Daily dose | Study groups |
|---|---|
| 250 mg or less | 1 |
| 250 mg to 500 mg | 1 |
| 500 mg to 1 g | 2 |
| 1 g to 2.5 g | 4 |
| 2.5 g to 5 g | 3 |
Commonly used together
2 of 15 study groups took Magnesium with something else, but nothing that 3 or more different studies gave.
15 study groups
| Study | |||
|---|---|---|---|
| Efficacy and safety of oral magnesium supplementation in reducing febrile neutropenia episodes in children with solid tumors treated with cisplatin-based chemotherapy: randomized clinical trial 2020 · magnesium supplement arm · Children aged 9 years or older with solid tumors receiving cisplatin-based chemotherapy | 250 mg | — | 50 |
| Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm) 2004 · group A (magnesium supplemented) · People with type 1 diabetes and chronic magnesium depletion | 300 mg | 5 years | 49 |
| Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death 1990 · Group A (magnesium-rich diet) · High-risk individuals aged 25–63 years, mostly male, with cardiovascular risk factors or coronary disease | 1.14 g | 10 years | 206 |
| [Magnesium, calcium, hemoglobin, hematocrit, estriol and human placental lactogen with magnesium substitution in pregnancy] 1990 · magnesium group · Pregnant women; age and specific condition not stated | 15 mmol | — | — |
| Mechanical colon cleansing for screening colonoscopy: A randomized controlled trial 2017 · PIE group · Outpatients at a VA hospital undergoing screening colonoscopy; mean age 62 years, 75% men | 296 mL | 1 day | 135 |
| Role of magnesium supplementation in the treatment of depression: A randomized clinical trial 2017 · Magnesium treatment period (immediate or delayed) · Adults aged 18 years or older with mild-to-moderate depression | 2 g | 6 weeks | 112 |
| Late outcome of a randomized study on oral magnesium for premature complexes 2014 · MgP group, first treatment · Adults with symptomatic premature ventricular or supraventricular complexes and structurally normal hearts | 3 g | 30 days | 45 |
| Late outcome of a randomized study on oral magnesium for premature complexes 2014 · MgP crossing-over group · Adults with symptomatic premature complexes who had initially received placebo and remained symptomatic | 3 g | 30 days | 21 |
| Late outcome of a randomized study on oral magnesium for premature complexes 2014 · MgP retreatment after relapse · Adults with symptomatic premature complexes who relapsed after initially receiving MgP | 3 g | 30 days | 17 |
| A randomized, controlled trial of oral sulfate solution versus polyethylene glycol for bowel preparation for colonoscopy 2025 · Group A (OSS) · Men and women aged 18–70 years undergoing screening, surveillance, or diagnostic colonoscopy | 1.6 g | 1 day | 324 |